Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Raises $25M in Private Placement

NEW YORK (GenomeWeb News) – Clinical Data has raised $25 million through the private placement of 1,514,922 shares of newly issued common stock to affiliates of Randal Kirk, chairman of the Newton, Mass.-based firm’s board of directors.
 
Clinical Data said that the purchase price was $16.44 per share, which was its closing price on Sept. 26, plus $.0625 per share, and warrants to purchase an additional 757,461 shares of common stock at $16.44 per share.
 
The publicly traded firm said that it would use the funds for general working capital purposes.
 
Shares of Clinical Data were up .6 percent at $16.54 in early Monday trade on the Nasdaq.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.